A Monte Carlo computer study of the total dose distribution from neutrons and prompt gamma emissions (but excluding the contribution from conversion and Auger electrons) for gadolinium neutron capture therapy of brain tumors has been carried out in order to test the theoretic feasibility of this modality using commercially available magnetic resonance contrast media. The three-dimensional dose distribution calculations were performed in a spherical head phantom with a spherical tumor at the center. Potentially achievable gadolinium concentrations of 150 micrograms/g of tissue in tumor and 3 micrograms/g in normal tissue were assumed with enrichment to 79.9% gadolinium-157, as supplied by Oak Ridge National Laboratory. Irradiation was assumed to be with a 2-keV monoenergetic cylindrical epithermal neutron beam having a radius of 4 cm. The three-dimensional thermal neutron fluence resulting from the 2-keV beam propagation through the tissue was modeled. For a single neutron beam, the maximum dose is delivered within the tumor but the dose is very inhomogeneous across the tumor volume due to rapid decrease of thermal neutron fluence with depth. Two parallel opposed neutron beams deliver to the interface of normal and malignant tissue 70%-80% of the maximum dose received at the center of the tumor. To deliver an average tumor dose of 500 cGy in 10 min would require a 2-keV source neutrons number of 8.0 x 10(11) per s within the geometry of the beam.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1118/1.596761 | DOI Listing |
Int J Mol Sci
October 2024
BIOCEV, First Faculty of Medicine, Charles University, Průmyslová 595, 25250 Vestec, Czech Republic.
The therapeutic potential of redox-active nanoscale materials as antioxidant- or reactive oxygen species (ROS)-inducing agents was intensely studied. Herein, we demonstrate that the synthesized and characterized GdVO:Eu and LaVO:Eu nanoparticles, which have been already shown to have redox-active, anti-inflammatory, antibacterial, and wound healing properties, both in vitro and in vivo, worsen oxidative stress of L929 cells triggered by hydrogen peroxide or -butyl hydroperoxide (tBuOOH) at the concentrations that are safe for intact L929 cells. This effect was observed upon internalization of the investigated nanosized materials and is associated with the cleavage of caspase-3 and caspase-9 without recruitment of caspase-8.
View Article and Find Full Text PDFSci Rep
November 2024
Technical University of Munich, Heinz Maier-Leibnitz Zentrum (MLZ), Lichtenbergstr. 1, 85748, Garching, Germany.
We present a versatile optical setup for high-resolution neutron imaging with an adaptable field of view and magnification that can resolve individual neutron absorption events with an image intensifier and a CMOS camera. Its imaging performance is characterized by evaluating the resolution limits of the individual optical components and resulting design aspects are discussed. Neutron radiography measurements of a Siemens star pattern were performed in event mode acquisition comparing two common high-resolution neutron scintillators, crystalline Gadolinium Gallium Garnet (GGG) and powdered Gadolinium Oxysulfide (GOS).
View Article and Find Full Text PDFSci Rep
October 2024
Department of Energy Engineering, Sharif University of Technology, Azadi Ave., P.O. Box: 11115-1639, Tehran, Iran.
The current study aims to introduce a new polymeric composite consisting of epoxy resin as the matrix and gadolinium oxide (GdO) as the neutron adsorption ingredient. The shielding performance of the composite was assessed by neutron attenuation experiments with an Am-Be source and polyethylene moderator. The results of these experiments showed an appreciable agreement with the Monte Carlo simulations.
View Article and Find Full Text PDFJ Chromatogr A
November 2024
Reactors Department, Egyptian Atomic Energy Authority, PO Box 13759, Cairo, Egypt.
Terbium-161 (Tb) is a promising therapeutic radionuclide that has gained significant attention in the field of nuclear medicine in recent years. Tb has several favorable characteristics that make it a valuable candidate for targeted radionuclide therapy. The production of No-carrier-added Tb was carried out by the neutron activation of natural gadolinium target in the Egyptian Second Research Reactor (ETRR-2) at a thermal neutron flux position of 1.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!